About daraxonrasib
Investigational RAS inhibitor
Used for
- Being studied for pancreatic cancer
- Being studied for certain lung cancers
Usual adult dose
No established routine dose; dosing is determined by clinical trial protocols.
Common side effects
- Skin rash
- Diarrhea
- Nausea
- Mouth sores
Important warnings
- Investigational medicine; safety and effectiveness remain under study
- Long-term risks are not fully established
Pregnancy
Safety during pregnancy has not been established.
Breastfeeding
Passage into breast milk and effects on breastfed infants are unknown.
Interactions
- Drug interactions are not fully established
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.